pharmaphorum
MAY 4, 2022
Testing drug compounds on a chip designed to mimic human organs sounds closer to science fiction than reality, yet the technology already exists and is already being put to use. Ben Hargreaves discovers how the technology could provide more accurate safety predictions and even discover new treatments. The limits of animal models in drug discovery are well known.
Drug Patent Watch
MAY 2, 2022
DrugPatentWatch has been named to Genetic Engineering News‘ Best of the Web list. The review by Genetic Engineering News profile highlighted the “new training modules designed to help you find…. The post DrugPatentWatch named “Best of the Web” by Genetic Engineering News appeared first on DrugPatentWatch - Make Better Decisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
MAY 6, 2022
Norfolk and Norwich University Hospitals Foundation Trust opens centre to increase survival rate among pregnant women managing other conditions
NY Times
MAY 5, 2022
Medication abortion allows patients to terminate early pregnancies at home. Some states are moving to limit it, while others are working to expand access.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
MAY 3, 2022
Israeli cancer diagnosis startup Imagene AI has raised $21.5 million in first-round financing for its cancer diagnosis platform based digitised imaging of biopsy samples. The Series A – led by Oracle co-founder Larry Ellison and fellow investors Dr David Ahus and Zebra Medical Vision founder Eyal Gura – includes $3 million in seed funding from venture capital firm Blumberg Capital.
Outsourcing Pharma
MAY 4, 2022
CPhI North America 2022 host city Philadelphia is set to become one of the worldâs biggest cell and gene therapy manufacturing hubs. But itâs just one of many centers of innovation that are helping drive the US pharma and biopharma industry.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
NY Times
MAY 3, 2022
Efforts to tease apart the vast swarm of proteins in venom — a field called venomics — have burgeoned in recent years, leading to important drug discoveries.
pharmaphorum
MAY 4, 2022
Cognitive problems affecting memory and attention can be substantial and long-lasting in patients who suffer severe COVID-19 infections, according to a study by researchers in the UK. The study used computerised cognitive assessments to follow-up 46 people who were hospitalised with COVID-19 at the Addenbrooke’s Hospital in Cambridge over a three-month period in 2020, comparing the results with 460 matched control subjects.
Outsourcing Pharma
MAY 4, 2022
An expert from Pharmatech Associates offers a glimpse into the evolution of CM and previews a lively discussion during the upcoming CPhI North America event.
Pharma Times
MAY 3, 2022
Byondis and Medac have entered into a license and collaboration agreement for form of targeted chemotherapy
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Channels
MAY 3, 2022
In Drug Channels Institute’s list of the top 15 pharmacies of 2021 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues. To complement that broader ranking, we present below our exclusive and updated list of the top 15 pharmacies based on specialty drug dispensing revenues in 2021.
pharmaphorum
MAY 3, 2022
Alain Labrique, PhD, professor and associate chair of research at Johns Hopkins Bloomberg School of Public Health (JHSPH) and chair of the World Health Organization (WHO) digital health guidelines development group discusses with us the ongoing research study, National Pandemic Pulse, he and his colleagues are performing in the US. Using comprehensive, repeat surveys deployed across the US population, Labrique and fellow researchers at JHSPH are measuring disparities and inequities due to COVID
Outsourcing Pharma
MAY 5, 2022
According to the 2022 EY CEO survey, life science executives are seeking to build resilience into their supply chains and dive into M&A opportunities.
Pharma Times
MAY 5, 2022
DELIVER represents the largest ever trial to address heart failure with preserved ejection fraction
NY Times
APRIL 30, 2022
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
pharmaphorum
MAY 3, 2022
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai. The new drug – Quviviq (daridorexant) – has been approved by the European Commission for adults who have been suffering insomnia for at least three months and are experiencing “considerable impact” on daytime functioning, according to the Swiss pharma company.
Outsourcing Pharma
MAY 5, 2022
A leader from the clinical technology company discusses some of the pain points in data collection and analysis, and tools that can help users level up.
Pharma Times
MAY 4, 2022
Platform will enable patients to monitor and share updates of their post-surgical wound healing
EMCrit Project
MAY 3, 2022
Which would you want?? The evidence may change your mind. EMCrit Project by Casey Albin.
pharmaphorum
MAY 6, 2022
Throughout my 30-year career, there have been many times it was obvious I stood out just because of my gender. I was often the only woman in the room, the meeting, or on the committee. Many colleagues had never worked with a woman leader before, let alone reported to a female boss. I’ve certainly faced barriers – sometimes literally. Exclusive behavior has many faces.
Drug Patent Watch
MAY 6, 2022
Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from one supplier. There are twenty-one…. The post New patent expiration for Gw Res drug EPIDIOLEX appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
MAY 4, 2022
Approval for Kymriah follows a positive CHMP opinion and is applicable to all 27 EU member states
Flip the Pharmacy
MAY 5, 2022
During a community outreach event, pharmacy students went to senior centers for brown bag medication reviews and blood pressure checks. The first year students (p1) were to take patients' blood pressures after the third year students (p3) conducted comprehensive medication reviews under a licensed pharmacist in the community and a fourth year pharmacy student (p4) for additional support.
pharmaphorum
MAY 3, 2022
A scientist working in Switzerland has become the fifth person to be convicted of attempting to steal trade secrets from pharmaceutical group GlaxoSmithKline in a case that stretched back several years. Gongda Xue (52), a Chinese citizen formerly working at the Friedrich Miescher Institute for Biomedical Research in Switzerland, has been found guilty of conspiracy to steal trade secrets in relation to medicines under development at GSK between January 2010 and January 2016.
Drug Patent Watch
MAY 5, 2022
Annual Drug Patent Expirations for UPNEEQ Upneeq is a drug marketed by Rvl Pharms and is included in one NDA. There are eight patents protecting this drug. This drug has…. The post New patent for Rvl Pharms drug UPNEEQ appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
MAY 3, 2022
The EC’s decision on the insomnia treatment was supported by phase 3 trial results
EnlivenHealth
MAY 5, 2022
Author: Ryan Haddock, Content Marketing Strategist Marketing is all about reaching people. You find the people who need what you have, and you explain why they should get it from you in the simplest way possible. And if it were that easy, anyone could do it. However, as many independent pharmacists find out, there The post Own Your Outreach: Getting the Most Out of Your Pharmacy Marketing Efforts appeared first on Pharmacy Software Solutions | FDS.
pharmaphorum
MAY 4, 2022
Hello Heart has raised $70 million in fourth-round financing to help grow its smartphone-based technology for people seeking to improve their heart health. Hello Heart blood pressure monitor. Hello Heart’s digital platform is based on a blood pressure monitor and smartphone app. It deploys artificial intelligence to help users track their blood pressure, pulse rate, weight and activity levels – as well as any medications taken – and give feedback and advice on how to adopt healthy practice
Syner-G
MAY 4, 2022
May 4, 2022 | Nathaniel DiTommaso, MS, Regulatory Affairs Manager. In May of 2014 and February of 2019 , the FDA released final Guidance for Industry outlining the Agency’s policies and procedures regarding expedited development and review programs for new drugs and biologics intended to treat serious or life-threatening conditions. Image courtesy of qimono at pixabay.com.
Pharma Times
MAY 5, 2022
Jakavi treats a potentially life-threatening condition which often effects transplant patients
Compounding Pharmacy of America
MAY 3, 2022
When a loved one is in hospice care, family members and caregivers need to make difficult, often emotional decisions. This often comes after an already-long road of supporting your loved one as they battle disease or through declining health. As a caregiver, you need to make sure your loved one is comfortable and getting everything […]. The post Loved Ones in Hospice Benefit From Compounding Meds appeared first on The Compounding Pharmacy of America.
pharmaphorum
MAY 5, 2022
AstraZeneca’s SGLT2 inhibitor Farxiga has hit the mark in a phase 3 heart failure trial that brings it back into contention with its main rival Jardiance from Boehringer Ingelheim and Eli Lilly. Top-line results from the DELIVER trial showed that Farxiga (dapagliflozin) was able to reduce the risk of cardiovascular deaths or worsening heart failure in patients who have heart failure with preserved ejection fraction (HFpEF), setting up filings for the new indication in the coming months.
Drug Patent Watch
MAY 3, 2022
Annual Drug Patent Expirations for NEXTERONE Nexterone is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from two suppliers. There are two patents…. The post New patent expiration for Baxter Hlthcare drug NEXTERONE appeared first on DrugPatentWatch - Make Better Decisions.
Board Vitals - Pharmacist
MAY 3, 2022
Happy Nurses Week 2022! During this week, which occurs annually on May 6-12, we take the time to recognize nurses and the impact they’ve made on the patient population. Many businesses offer discounts and freebies to show their support for nurses around the country. Here are some of the top Nurses Week promotions for 2022. . The below information was collected for Nurses Week 2022 and may include the previous year’s offers as some companies have not announced their offers as of publishing.
EMCrit Project
MAY 3, 2022
Catatonia is an important cause of altered mental status which is often overlooked among critically ill patients. Although traditionally associated with schizophrenia, catatonia can result from a variety of psychiatric, neurologic, and medical problems (similar to delirium). It is important to diagnose catatonia, because otherwise patients are likely to be incorrectly labeled as having delirium […].
Expert insights. Personalized for you.
142 
Let's personalize your content